Get In Touch

Bioavailability enhancer is an agent that is combined with a drug to increase the bioefficacy and bioavailability of the drug. There is no typical pharmacological activity of the bioavailability enhancer at the dose used. Bioavailability is when a fraction of a drug or other therapeutically active substances enters the blood circulation and is made available at the target site of action. The bioavailability enhancer reduces the dosage of a drug by increasing the drug’s level in the blood stream of a patient to achieve a therapeutic effect, and thus increasing the bioefficacy of the drug. Piperine is the most effective bioavailability enhancer in the world. Major categories of drugs that have bioavailability enhancing capability are respiratory, cardiovascular, GIT, CNS, anticancer, antibiotics, and others. Bioavailability boosting technologies not only help in generic versions of existing drugs and biosimilars, but also for product development of new biological and chemical entities.

The advantages of bioavailability enhancers such as the ability to reduce drug dosage and drug cost, improve compliance, ecological advantage, reduce risk of side effects or adverse drug reactions, reduce incidence of drug resistance, and increase efficacy of the drug are driving the growth of the market. These agents reduce the raw materials used for drug manufacturing. In addition, the increasing awareness about the advantages of bioavailability enhancers is likely to boost the market growth during the forecast period. Till now, billions of dollars are wasted globally due to poor bioavailability of drugs; but with the increasing awareness about bioavailability enhancers, there is a growing demand for these agents. 

The global bioavailability enhancers market can be segmented as source of origin, target site of action, end-user, and region. On the basis of source of origin, the market for bioavailability enhancers is segmented as plant based and animal based. The plant based segment generates a higher revenue as compared to the animal based segment as more research and development activities are conducted on plant-based enhancers. On the basis of target site of action, the market is segmented as intestine, liver, metabolizing enzymes, pathogens, DNA and protein binding sites of pathogens, tumor tissue, blood-brain barrier, and others. Based on end-user, the market is segmented as pharmaceutical companies, research and development institutes, academic institutes, and others. 

Geographically, the market for bioavailability enhancers is distributed over North America, Europe, Asia Pacific, and rest of the world. North America is the largest market for bioavailability enhancers due to rise in awareness and high research and development on bioavailability enhancers. Rising demand for bioavailability enhancers has led to the growth of this market. Europe is the second largest market due to high awareness about the advantages of bioavailability enhancers. Asia Pacific is projected to be the most promising market during the forecast period due to the fact that the awareness of the bioavailability enhancers was started from Ayurveda medicine which originated in India and the availability of plants containing bioavailability enhancing qualities. 

Key players operating in the global bioavailability enhancers market include Merck Millipore, Catalent, Dow Pharmaceutical Sciences, Inc., SEPS Pharma, Alkermes plc, Aptuit LLC, and BASF.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Bioavailability Enhancers Market

Pre Book